{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:21:51Z","timestamp":1784193711256,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102327","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:20:31Z","timestamp":1744201231000},"page":"102327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Co-occurrence of EIF1AX, SF3B1, or BAP1 variants in uveal melanomas: A case series and review"],"prefix":"10.1016","volume":"38","author":[{"given":"Henry C.","family":"Skrehot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer F.","family":"Alsoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Schefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2025.102327_bib1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102327_bib2","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","article-title":"Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma","volume":"119","author":"Onken","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102327_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.ajoc.2025.102327_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","article-title":"Punctuated evolution of canonical genomic aberrations in uveal melanoma","volume":"9","author":"Field","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajoc.2025.102327_bib5","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.ajoc.2025.102327_bib6","first-page":"6541","article-title":"Clinical, histopathological and cytogenetic prognosticators in uveal melanoma - a comprehensive review","volume":"37","author":"Berus","year":"2017","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ajoc.2025.102327_bib7","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","article-title":"Integrative analysis identifies four molecular and clinical subsets in uveal melanoma","volume":"32","author":"Robertson","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ajoc.2025.102327_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.exer.2012.04.010","article-title":"Monosomy 3 status of uveal melanoma metastases is associated with rapidly progressive tumors and short survival","volume":"100","author":"Abdel-Rahman","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2025.102327_bib9","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.11941.1","article-title":"Recent advancements in the management of retinoblastoma and uveal melanoma","volume":"7","author":"Schefler","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.ajoc.2025.102327_bib10","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.24.00447","article-title":"15-Gene expression profile and PRAME as integrated prognostic test for uveal melanoma: first report of collaborative ocular oncology group study No. 2 (COOG2.1)","volume":"42","author":"Harbour","year":"2024","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ajoc.2025.102327_bib11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/IAE.0000000000004153","article-title":"Comprehensive molecular profiling of uveal melanoma evaluated with gene expression profiling, preferentially expressed antigen in melanoma expression, and next-generation sequencing","volume":"44","author":"Alsoudi","year":"2024","journal-title":"Retina Phila Pa"},{"key":"10.1016\/j.ajoc.2025.102327_bib12","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2025.102327_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.ajoc.2025.102327_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/bjc.2017.259","article-title":"GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi","volume":"117","author":"Vader","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ajoc.2025.102327_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12885-021-07865-x","article-title":"Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma","volume":"21","author":"Nell","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ajoc.2025.102327_bib16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3390\/cancers12041039","article-title":"Targeted next-generation sequencing of 117 routine clinical samples provides further insights into the molecular landscape of uveal melanoma","volume":"12","author":"Thornton","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ajoc.2025.102327_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/cancers15030775","article-title":"Genetics and RNA regulation of uveal melanoma","volume":"15","author":"Barbagallo","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ajoc.2025.102327_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamaophthalmol.2018.0561","article-title":"Yield, techniques, and complications of transvitreal and transscleral biopsies in small uveal melanoma","volume":"136","author":"Kim","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102327_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102327_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035295","article-title":"Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families","volume":"7","author":"Njauw","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2025.102327_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nbt.3391","article-title":"Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity","volume":"34","author":"Chang","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ajoc.2025.102327_bib22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/340692a0","article-title":"GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours","volume":"340","author":"Landis","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.ajoc.2025.102327_bib23","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2025.102327_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102327_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/gcc.22129","article-title":"Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases","volume":"53","author":"Pilarski","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ajoc.2025.102327_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094554","article-title":"Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing","volume":"9","author":"Bodian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2025.102327_bib28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41588-019-0440-9","article-title":"The genetic evolution of metastatic uveal melanoma","volume":"51","author":"Shain","year":"2019","journal-title":"Nat Genet"},{"issue":"23","key":"10.1016\/j.ajoc.2025.102327_bib29","article-title":"Delays between uveal melanoma diagnosis and treatment increase the risk of metastatic death","volume":"S0161\u20136420","author":"St\u00e5lhammar","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102327_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fgene.2016.00059","article-title":"Gnaq and Gna11 in the endothelin signaling pathway and melanoma","volume":"7","author":"Urtatiz","year":"2016","journal-title":"Front Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib31","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","article-title":"Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4","volume":"7","author":"Johansson","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajoc.2025.102327_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","article-title":"Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma","volume":"48","author":"Moore","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ajcp\/aqac019","article-title":"Genomic profiling of metastatic uveal melanoma shows frequent coexisting BAP1 or SF3B1 and GNAQ\/GNA11 mutations and correlation with prognosis","volume":"158","author":"Isaacson","year":"2022","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajoc.2025.102327_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/TACG.S69210","article-title":"The genetics of uveal melanoma: current insights","volume":"9","author":"Helgadottir","year":"2016","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib35","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajoc.2025.102327_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41525-023-00374-9","article-title":"Clinically significant germline pathogenic variants are missed by tumor genomic sequencing","volume":"8","author":"Stout","year":"2023","journal-title":"NPJ Genomic Med"},{"key":"10.1016\/j.ajoc.2025.102327_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joco.2018.02.005","article-title":"Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma","volume":"30","author":"Masoomian","year":"2018","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102327_bib38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/s41431-023-01448-z","article-title":"Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome","volume":"31","author":"Lalloo","year":"2023","journal-title":"Eur J Hum Genet EJHG"},{"key":"10.1016\/j.ajoc.2025.102327_bib39","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-15-2071","article-title":"PRAME as an independent biomarker for metastasis in uveal melanoma","volume":"22","author":"Field","year":"2016","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.ajoc.2025.102327_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.ophtha.2016.01.023","article-title":"Uveal melanomas with SF3B1 mutations: a distinct subclass associated with late-onset metastases","volume":"123","author":"Yavuzyigitoglu","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102327_bib41","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/cancers14030846","article-title":"Identification of early-onset metastasis in SF3B1 mutated uveal melanoma","volume":"14","author":"Drabarek","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ajoc.2025.102327_bib42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/1878-0261.13128","article-title":"Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence","volume":"16","author":"Yu","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajoc.2025.102327_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-016-0272-0","article-title":"SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas","volume":"4","author":"K\u00fcsters-Vandevelde","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.ajoc.2025.102327_bib44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib45","first-page":"1021","article-title":"Beyond myeloid neoplasms germline guidelines: validation of the thresholds criteria in the search of germline predisposition variants","volume":"5","author":"Mestre","year":"2024","journal-title":"EJH"},{"key":"10.1016\/j.ajoc.2025.102327_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5644\/ama2006-124.322","article-title":"Characterization and clinical significance of EIF1AX mutations and Co-mutations in cytologically indeterminate thyroid nodules: a 5-year retrospective analysis","volume":"50","author":"Gargano","year":"2021","journal-title":"Acta Medica Acad"},{"key":"10.1016\/j.ajoc.2025.102327_bib47","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1167\/iovs.14-14550","article-title":"Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma","volume":"55","author":"Ewens","year":"2014","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2025.102327_bib48","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.ajoc.2025.102327_bib49","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.trecan.2023.08.011","article-title":"Variant allele frequency: a decision-making tool in precision oncology?","volume":"9","author":"Boscolo","year":"2023","journal-title":"Trends Cancer"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625000805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:58Z","timestamp":1760146078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625000805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":49,"alternative-id":["S2451993625000805"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102327","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-occurrence of EIF1AX, SF3B1, or BAP1 variants in uveal melanomas: A case series and review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102327"}}